Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic
Release Date: 07/18/2025
Neurology Minute
In part four of this foundational neurology series, Casey Kozak explores neuroleptic malignant syndrome and highlights key similarities and differences with malignant hyperthermia.
info_outlineNeurology Minute
In part three of this foundational neurology series, Casey Kozak discusses malignant hyperthermia caused by inhaled anesthetics and depolarizing neuromuscular blockers.
info_outlineNeurology Minute
Dr. Trey Bateman and Dr. David T. Jones discuss how the StateViewer system leverages FDG-PET imaging and machine learning to improve diagnostic accuracy and clinical decision-making for Alzheimer disease and related disorders. Show reference:
info_outlineNeurology Minute
Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation. show reference:
info_outlineNeurology Minute
Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society’s 67th Annual Scientific Meeting in June 2025. Show reference:
info_outlineNeurology Minute
In part two of this foundational neurology series, Casey Kozak discusses key differences and clinical implications of subdural hematomas.
info_outlineNeurology Minute
In part one of this foundational neurology series, Casey Kozak discusses how to interpret a head CT as well as the clinical presentation of epidural hematomas.
info_outlineNeurology Minute
Drs. Jeff Ratliff, Michael A. Van Es, and Eva de Boer discuss what this study taught us about the value and application of the 2020 consensus criteria for diagnosing primary lateral sclerosis. Show reference:
info_outlineNeurology Minute
Drs. BJ Hicks, Birgitte Hede Ebbesen, and Boris Modrau discuss fatigue following transient ischemic attack and examine the characteristics of patients who experience pathologic fatigue. Show reference:
info_outlineNeurology Minute
In the final episode of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss when and where to use clinical metagenomic next-generation sequencing tests, as well as the limitations of these tests. Show reference:
info_outlineDr. Trey Bateman and Dr. Gregg Day discuss the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care.
Show reference:
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70316